SANGAMO THERAPEUTICS, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 251.18 thousand shares for the 3-month period ending 2024-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2025-05-12
- SANGAMO THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2024-03-31 was 251.18K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month |
|---|---|
| 2024-03-31 | 251.18K shares 10-Q · filed 2025-05-12 |